NZ HIV Medicine Research Review Issue 48

In this issue:

  -  2013–2019 trends and risk factors for HIV in UK gay/bisexual MSM
  -  Weight gain and related comorbidities following ART initiation in the 2000s
  -  Cabotegravir for preventing HIV in cisgender men and transgender women
  -  Impact of COVID-19 on HIV testing and provision of care across four continents
  -  Anal HPV and HSILs in men according to HIV status, sexuality and age
  -  Starting long-acting cabotegravir + rilpivirine as injections or with oral lead-in for HIV-1
  -  Factors associated with SARS-COV-2 diagnosis and severe COVID-19 in HIV
  -  Long-acting cabotegravir + rilpivirine every 2 months in HIV-1
  -  Humoral and cellular immune responses to Pfizer COVID-19 vaccine in HIV
  -  High resistance in Enterobacterales in HIV

Please login below to download this issue (PDF)